Mark Flasar

669 total citations
27 papers, 468 citations indexed

About

Mark Flasar is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Mark Flasar has authored 27 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 17 papers in Genetics and 8 papers in Surgery. Recurrent topics in Mark Flasar's work include Inflammatory Bowel Disease (17 papers), Microscopic Colitis (16 papers) and Diverticular Disease and Complications (4 papers). Mark Flasar is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Microscopic Colitis (16 papers) and Diverticular Disease and Complications (4 papers). Mark Flasar collaborates with scholars based in United States and Vietnam. Mark Flasar's co-authors include Raymond K. Cross, Eric Goldberg, Mary‐Claire Roghmann, Roxana Samimi, Stephen M. Kavic, Kathleen Tracy, Sandra Quezada, Mark Lazarev, Jennifer Holder‐Murray and Stefan D. Holubar and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

Mark Flasar

27 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Flasar United States 10 249 239 214 85 57 27 468
Raymond E. Joseph United States 10 522 2.1× 441 1.8× 320 1.5× 18 0.2× 231 4.1× 26 929
Saransh Jain India 16 272 1.1× 266 1.1× 389 1.8× 35 0.4× 117 2.1× 38 628
Aharon Halak Israel 10 215 0.9× 182 0.8× 163 0.8× 23 0.3× 168 2.9× 11 488
Anne Tuskey United States 11 223 0.9× 175 0.7× 166 0.8× 16 0.2× 64 1.1× 19 418
Hao Zeng China 14 37 0.1× 104 0.4× 453 2.1× 47 0.6× 261 4.6× 21 541
V. Imbesi Italy 17 597 2.4× 497 2.1× 639 3.0× 32 0.4× 42 0.7× 28 1.1k
Antoine Petitcollin France 16 98 0.4× 163 0.7× 108 0.5× 14 0.2× 44 0.8× 25 575
Inger Bak Andersen Denmark 6 383 1.5× 350 1.5× 264 1.2× 12 0.1× 16 0.3× 10 562
Raina Shivashankar United States 9 334 1.3× 299 1.3× 195 0.9× 7 0.1× 28 0.5× 21 575
Shinji Okabayashi Japan 11 213 0.9× 180 0.8× 119 0.6× 15 0.2× 53 0.9× 34 337

Countries citing papers authored by Mark Flasar

Since Specialization
Citations

This map shows the geographic impact of Mark Flasar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Flasar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Flasar more than expected).

Fields of papers citing papers by Mark Flasar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Flasar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Flasar. The network helps show where Mark Flasar may publish in the future.

Co-authorship network of co-authors of Mark Flasar

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Flasar. A scholar is included among the top collaborators of Mark Flasar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Flasar. Mark Flasar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patil, Seema, Mark Flasar, Jay Lin, et al.. (2018). Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn’s Disease. Digestive Diseases and Sciences. 64(1). 60–67. 2 indexed citations
2.
Shah, Kamini, et al.. (2017). Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia. World Journal of Clinical Oncology. 8(5). 398–404. 9 indexed citations
3.
Flasar, Mark, Jingdong Chao, A. Burak Ozbay, et al.. (2016). Biological and Immunomodulator Use in Crohnʼs Disease in a Medicaid Population. Inflammatory Bowel Diseases. 22(5). 1056–1064. 4 indexed citations
4.
Jambaulikar, Guruprasad, Joy Lee, David A. Schwartz, et al.. (2015). Tu1262 Internal Locus of Control and Increased Self-Efficacy Are Associated With Higher Quality of Life in Patients With Inflammatory Bowel Disease. Gastroenterology. 148(4). S–841. 1 indexed citations
5.
Holubar, Stefan D., Jennifer Holder‐Murray, Mark Flasar, & Mark Lazarev. (2015). Anti–Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 21(11). 2658–2672. 25 indexed citations
6.
Haidar, Sam, Xinyuan Zhang, Wenlei Jiang, et al.. (2015). Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir. Journal of Pharmaceutical Sciences. 105(2). 996–1005. 49 indexed citations
7.
Schwartz, David A., Leyla Ghazi, Jason M. Swoger, et al.. (2015). Sa1263 A Prospective Multicenter Trial Evaluating the Benefit of Initial Seton Placement Prior to Starting Anti-TNF Therapy for the Treatment of Crohn's Perianal Fistulas. Gastroenterology. 148(4). S–274. 4 indexed citations
8.
Ghazi, Leyla, et al.. (2014). Racial Differences in Disease Activity and Quality of Life in Patients with Crohn’s Disease. Digestive Diseases and Sciences. 59(10). 2508–2513. 13 indexed citations
9.
Zullow, Samantha, et al.. (2014). A Health Survey of Gastroenterologist Prescribing Practices of Adalimumab for Treatment of Crohn's Disease: Final Results.. PubMed. 10(8). 503–509. 3 indexed citations
10.
Cross, Raymond K., et al.. (2013). Anti-Tumor Necrosis Factor Therapy Is Associated With Infections after Abdominal Surgery in Crohn's Disease Patients. The American Journal of Gastroenterology. 108(4). 583–593. 87 indexed citations
11.
Ghazi, Leyla, et al.. (2013). Step Up Versus Early Biologic Therapy for Crohnʼs Disease in Clinical Practice. Inflammatory Bowel Diseases. 19(7). 1397–1403. 14 indexed citations
12.
Aslinia, Florence & Mark Flasar. (2012). Endoscopic ferromagnetic object retrieval by use of a simple magnet (with video). Gastrointestinal Endoscopy. 76(3). 667–668. 2 indexed citations
13.
Patil, Seema, et al.. (2012). Anti-TNF Therapy Is Associated with Decreased Imaging and Radiation Exposure in Patients with Crohnʼs Disease. Inflammatory Bowel Diseases. 19(1). 92–98. 5 indexed citations
14.
Khurana, Sandeep, et al.. (2010). Dialysis Reduces Portal Pressure in Patients With Chronic Hepatitis C. Artificial Organs. 34(7). 570–579. 6 indexed citations
15.
Flasar, Mark, et al.. (2010). Racial Differences in Use of Biologics for Crohnʼs Disease in a Medicaid Population. The American Journal of Gastroenterology. 105. S443–S443. 1 indexed citations
16.
Flasar, Mark, et al.. (2008). Racial Differences in Disease Extent and Severity in Patients with Ulcerative Colitis: A Retrospective Cohort Study. Digestive Diseases and Sciences. 53(10). 2754–2760. 25 indexed citations
17.
Flasar, Mark, et al.. (2007). Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: A retrospective cohort study. Inflammatory Bowel Diseases. 14(1). 13–19. 49 indexed citations
18.
Flasar, Mark & Eric Goldberg. (2006). Acute Abdominal Pain. Medical Clinics of North America. 90(3). 481–503. 94 indexed citations
19.
Flasar, Mark, Raymond K. Cross, & Eric Goldberg. (2006). Acute Abdominal Pain. Primary Care Clinics in Office Practice. 33(3). 659–684. 18 indexed citations
20.
Fink, Jeffrey C., Mark Flasar, Jonathan J. Harrington, Matthew R. Weir, & Stephen T. Bartlett. (1998). ALOPECIA TOTALIS RELATED TO TACROLIMUS USE FOLLOWING KIDNEY AND PANCREAS TRANSPLANTATION. Transplantation. 65(12). S168–S168. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raymond E. Joseph Breakdown of academic impact, for papers by Saransh Jain Breakdown of academic impact, for papers by Aharon Halak Breakdown of academic impact, for papers by Anne Tuskey Breakdown of academic impact, for papers by Hao Zeng Breakdown of academic impact, for papers by V. Imbesi Breakdown of academic impact, for papers by Antoine Petitcollin Breakdown of academic impact, for papers by Inger Bak Andersen Breakdown of academic impact, for papers by Raina Shivashankar Breakdown of academic impact, for papers by Shinji Okabayashi
Rankless by CCL
2026